Publicaciones en colaboración con investigadores/as de Complejo Asistencial Universitario de León (21)

2024

  1. Correction to: Protective Effect of Protocatechuic Acid on TNBS-Induced Colitis in Mice Is Associated with Modulation of the SphK/S1P Signaling Pathway (Nutrients, (2017), 9, 3, (288), 10.3390/nu9030288)

    Nutrients

  2. Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Clinical Pharmacology and Therapeutics, Vol. 116, Núm. 2, pp. 328-345

2023

  1. Correction to: Stabilization of Hypoxia-Inducible Factors and BNIP3 Promoter Methylation Contribute to Acquired Sorafenib Resistance in Human Hepatocarcinoma Cells (Cancers, (2019), 11, 12, (1984), 10.3390/cancers11121984)

    Cancers

2019

  1. Beneficial effects of exercise on gut microbiota functionality and barrier integrity, and gut-liver crosstalk in an in vivo model of early obesity and non-alcoholic fatty liver disease

    DMM Disease Models and Mechanisms, Vol. 12, Núm. 5

  2. Stabilization of hypoxia-inducible factors and BNIP3 promoter methylation contribute to acquired sorafenib resistance in human hepatocarcinoma cells

    Cancers, Vol. 11, Núm. 12

2018

  1. Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors

    Experimental and Molecular Medicine, Vol. 50, Núm. 10

2017

  1. Effects of oral glutamine on inflammatory and autophagy responses in cancer patients treated with abdominal radiotherapy: A pilot randomized trial

    International Journal of Medical Sciences, Vol. 14, Núm. 11, pp. 1065-1071

  2. Melatonin enhances sorafenib actions in human hepatocarcinoma cells by inhibiting mTORC1/p70S6K/HIF-1α and hypoxiamediated mitophagy

    Oncotarget, Vol. 8, Núm. 53, pp. 91402-91414

  3. Protective effect of protocatechuic acid on TNBS-induced colitis in mice is associated with modulation of the SphK/S1P signaling pathway

    Nutrients, Vol. 9, Núm. 3

2016

  1. Modulation of autophagy by sorafenib: Effects on treatment response

    Frontiers in Pharmacology, Vol. 7, Núm. JUN

2015

  1. Melatonin Activates Endoplasmic Reticulum Stress and Apoptosis in Rats with Diethylnitrosamine-Induced Hepatocarcinogenesis

    PLoS ONE, Vol. 10, Núm. 12

2014

  1. Inhibition of matrix metalloproteinase-9 and nuclear factor kappa B contribute to melatonin prevention of motility and invasiveness in HepG2 liver cancer cells

    Journal of Pineal Research, Vol. 56, Núm. 1, pp. 20-30

2013

  1. Inhibition of VEGF expression through blockade of Hif1α and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells

    British Journal of Cancer, Vol. 109, Núm. 1, pp. 83-91

2011

  1. Melatonin modulation of intracellular signaling pathways in hepatocarcinoma HepG2 cell line: Role of the MT1 receptor

    Journal of Pineal Research, Vol. 51, Núm. 4, pp. 463-471

2009

  1. Changes in the expression of melatonin receptors induced by melatonin treatment in hepatocarcinoma HepG2 cells

    Journal of Pineal Research, Vol. 47, Núm. 4, pp. 330-338

2007

  1. Cell-cycle inhibition by TNP-470 in an in vivo model of hepatocarcinoma is mediated by a p53 and p21WAF1/CIP1 mechanism

    Translational Research, Vol. 149, Núm. 1, pp. 46-53

  2. Changes in the antioxidant system by TNP-470 in an in vivo model of hepatocarcinoma

    Translational Research, Vol. 150, Núm. 3, pp. 189-196

  3. Modelos experimentales sobre shock hemorrágico

    Nutricion Hospitalaria, Vol. 22, Núm. 2, pp. 190-198

2005

  1. Antiangiogenic treatment of cancer

    Cirugia Espanola, Vol. 78, Núm. 1, pp. 3-11

2003

  1. TNP-470 inhibits oxidative stress, nitric oxide production and nuclear factor Kappa B activation in a rat model of hepatocellular carcinoma

    Free Radical Research, Vol. 37, Núm. 8, pp. 841-848